Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: Surgical resection followed by chemotherapy versus chemotherapy alone

Blood

Volumn 117, Issue 6, 2011, Pages 1958-1965

  Kim, Seok Jin ^a   Kang, Hye Jin ^b   Kim, Jin Seok ^c   Oh, Sung Yong ^d   Choi, Chul Won ^e   Lee, Soon Il ^f   Won, Jong Ho ^g   Kim, Min Kyoung ^h   Kwon, Jung Hye ⁱ   Mun, Yeung Chul ^j   Kwak, Jae Yong ^k   Kwon, Jung Mi ^l   Hwang, In Gyu ^m   Kim, Hyo Jung ⁱ   Park, Jinny ⁿ   Oh, Sukjoong ^o   Huh, Jooryung ^p   Ko, Young Hyeh ^a   Suh, Cheolwon ^p   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Dong A University College of Medicine   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Dankook University College of Medicine   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Yeungnam University College of Medicine   (South Korea)

ⁱ Hallym University College of Medicine   (South Korea)

^j Ewha Womans University School of Medicine   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Jeju National University School of Medicine   (South Korea)

^m Chung Ang University College of Medicine   (South Korea)

ⁿ Gachon University   (South Korea)

^o Sungkyunkwan University School of Medicine   (South Korea)

^p University of Ulsan College of Medicine   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; COMPARATIVE EFFECTIVENESS; FEMALE; HUMAN; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE PLANNING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

EID: 79951489806     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-06-288480     Document Type: Article

References (23)

1. d'Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol. 1994;12(8):1673-1684.
2. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas: 1. Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8(8):727-737. (Pubitemid 27397895)
3. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462-2473. (Pubitemid 36542485)
4. Mihaljevic B, Nedeljkov-Jancic R, Vujicic V, Antic D, Jankovic S, Colovic N. Primary extranodal lymphomas of gastrointestinal localizations: a single institution 5-yr experience. Med Oncol. 2006;23(2):225-235. (Pubitemid 43780306)
5. Connor J, Ashton-Key M. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different: an immunohistochemical and clinical study. Histopathology. 2007; 51(5):697-703. (Pubitemid 47572880)
6. Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12(1):53-58. (Pubitemid 32162448)
7. Wong MT, Eu KW. Primary colorectal lymphomas. Colorectal Dis. 2006;8(7):586-591. (Pubitemid 44210111)
8. Kako S, Oshima K, Sato M, et al. Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. Leuk Lymphoma. 2009:1-7.
9. Li B, Shi YK, He XH, et al. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol. 2008;87(4):375-381.
10. Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. 2007;31(3):359-364. (Pubitemid 46073176)
11. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol. 2003;21(14):2740-2746. (Pubitemid 46606320)
12. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235-242. (Pubitemid 34438862)
13. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract: report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80-89.
14. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693-707. (Pubitemid 8405865)
15. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer. 1980;46(1):215-222.
16. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397-400. (Pubitemid 24159642)
17. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-376. (Pubitemid 23073154)
18. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207-214. (Pubitemid 11167383)
19. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861-3873. (Pubitemid 32880065)
20. Binn M, Ruskone-Fourmestraux A, Lepage E, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003;14(12):1751-1757. (Pubitemid 38035082)
21. Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050-7059.
22. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma: results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001; 19(18):3874-3883. (Pubitemid 32880066)
23. Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004;45(2):339-344. (Pubitemid 38181438)